PL419960A1 - Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids - Google Patents

Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids

Info

Publication number
PL419960A1
PL419960A1 PL419960A PL41996016A PL419960A1 PL 419960 A1 PL419960 A1 PL 419960A1 PL 419960 A PL419960 A PL 419960A PL 41996016 A PL41996016 A PL 41996016A PL 419960 A1 PL419960 A1 PL 419960A1
Authority
PL
Poland
Prior art keywords
amino acids
determination
analysis
gradient elution
subject
Prior art date
Application number
PL419960A
Other languages
Polish (pl)
Inventor
Lucyna KONIECZNA
Tomasz BĄCZEK
Maciej NIEDŹWIECKI
Original Assignee
Gdański Uniwersytet Medyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gdański Uniwersytet Medyczny filed Critical Gdański Uniwersytet Medyczny
Priority to PL419960A priority Critical patent/PL419960A1/en
Priority to EP17840505.6A priority patent/EP3559675B1/en
Priority to PL17840505.6T priority patent/PL3559675T3/en
Priority to PCT/PL2017/000130 priority patent/WO2018117881A1/en
Publication of PL419960A1 publication Critical patent/PL419960A1/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

Przedmiotem zgłoszenia jest sposób oznaczania aminokwasów w osoczu i płynie mózgowo - rdzeniowym. Przedmiotowy sposób oznaczania aminokwasów w materiale biologicznym charakteryzuje się tym, że analiza aminokwasów w materiale jest w następujących etapach: - przygotowanie próbki materiału biologicznego do analizy chromatograficznej, - rozdzielenie następuje poprzez chromatografię cieczową sprzężoną ze spektrometrią mas (LC - MS) - rozdział 21 aminokwasów następuje poprzez chromatografię oddziaływań hydrofilowych HILTC z wykorzystaniem polarnej kolumny, - faza ruchoma składała się z fazy A: 10 mM mrówczan amonu (pH3) w wodzie i B: 10 mM mrówczan amonu w acetonitrylu w warunkach elucji gradientowej, - przepływ fazy ruchomej wynosi 1 ml/min, - temperatura gazu rozpylającego: 250°C, przepływ gazu rozpylającego: 12 L/min, napięcie przyłożone do kapilary: 3 kV, napięcie fragmentacyjne zależne od substancji (zakres od 75 do 125), - czas pojedynczej analizy 21 aminokwasów wraz z równoważeniem kolumny wynosi 30 min, - rozdzielenie aminokwasów nastąpiło w warunkach elucji gradientowej. Zgłoszenie obejmuje też zastosowanie przedmiotowego sposobu do oznaczania aminokwasów u osób chorych na białaczkę limfoblastyczną w momencie postawienia diagnozy oraz podczas chemioterapii.The subject of the application is a method for determining amino acids in plasma and cerebrospinal fluid. The subject method of determining amino acids in biological material is characterized by the fact that the analysis of amino acids in the material is in the following stages: - preparation of a sample of biological material for chromatographic analysis, - separation is carried out by liquid chromatography coupled with mass spectrometry (LC - MS) - 21 amino acids are separated by HILTC hydrophilic interaction chromatography using a polar column, - the mobile phase consisted of phase A: 10 mM ammonium formate (pH3) in water and B: 10 mM ammonium formate in acetonitrile under gradient elution, - the mobile phase flow is 1 ml / min, - atomizing gas temperature: 250 ° C, atomizing gas flow: 12 L / min, voltage applied to the capillary: 3 kV, fragmentation voltage dependent on the substance (range from 75 to 125), - single analysis time 21 amino acids with balancing columns are 30 min, - amino acid separation will occur of the gradient elution conditions. The application also includes the use of the subject method for the determination of amino acids in patients with lymphoblastic leukemia at the time of diagnosis and during chemotherapy.

PL419960A 2016-12-22 2016-12-22 Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids PL419960A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL419960A PL419960A1 (en) 2016-12-22 2016-12-22 Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids
EP17840505.6A EP3559675B1 (en) 2016-12-22 2017-12-21 A method for monitoring of amino acids in biological material
PL17840505.6T PL3559675T3 (en) 2016-12-22 2017-12-21 A method for monitoring of amino acids in biological material
PCT/PL2017/000130 WO2018117881A1 (en) 2016-12-22 2017-12-21 A method for monitoring of amino acids in biological material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL419960A PL419960A1 (en) 2016-12-22 2016-12-22 Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids

Publications (1)

Publication Number Publication Date
PL419960A1 true PL419960A1 (en) 2018-07-02

Family

ID=62705205

Family Applications (1)

Application Number Title Priority Date Filing Date
PL419960A PL419960A1 (en) 2016-12-22 2016-12-22 Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids

Country Status (1)

Country Link
PL (1) PL419960A1 (en)

Similar Documents

Publication Publication Date Title
WO2017152689A1 (en) High-sensitivity analysis method for imatinib genotoxic impurities
Fortier et al. Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs
Do et al. Analysis of alkaloids in Lotus (Nelumbo nucifera Gaertn.) leaves by non-aqueous capillary electrophoresis using ultraviolet and mass spectrometric detection
JP2019503493A5 (en)
Déglon et al. On-line desorption of dried blood spot: a novel approach for the direct LC/MS analysis of μ-whole blood samples
Yaroshenko et al. Matrix effect and methods for its elimination in bioanalytical methods using chromatography-mass spectrometry
JP6385103B2 (en) Supercritical fluid chromatograph with normal / reverse phase column and analytical method using it
Hu et al. Rapid detection of adulterated drugs in herbal dietary supplements by wooden-tip electrospray ionization mass spectrometry
WO2018126064A3 (en) Single-use, disposable high-pressure liquid chromatography columns for high-throughput analysis
Peš et al. Off-line coupling of microcolumn separations to desorption mass spectrometry
SG11201908520TA (en) Method for simultaneous quantification of monoclonal antibodies
GB2523873A (en) Systems, devices and methods for connecting a chromatography system to a mass spectrometer
RU2015112500A (en) SYSTEM FOR DOSING THE SAMPLE INTO A BUFFER LIQUID
Chen et al. Construction of discontinuous capillary isoelectric focusing system and its application in pre-fractionation of exosomal proteins
CN106908525B (en) A kind of analysis method measuring SC 69124 intermediate with SC 69124 in relation to substance
CN105866315B (en) The assay method of amino acid in a kind of tobacco juice for electronic smoke
PL419960A1 (en) Method for monitoring the process of acute lymphoblastic leukaemia by means of determination of amino acids
Wen et al. Gradient elution LC-MS determination of dasatinib in rat plasma and its pharmacokinetic study
JP5888383B2 (en) interface
DENG et al. Rapid HPLC testing method for lipid-regulating drugs illegally added in traditional Chinese medicines and health food∗
WO2019069625A1 (en) Supercritical fluid chromatograph, and method for analysis by supercritical fluid chromatography
EA202090477A1 (en) METHOD FOR QUANTITATIVE DETERMINATION OF ORGANIC ACID CONTENT IN CRUDE OIL
Hayama et al. Selective extraction of nucleotides with Fluorous biphasic system utilizing Perfluoroalkylamine as an ion-pair reagent
Liang et al. Analysis of monosaccharide composition of twelve polysaccharides by pre-column derivatization procedure UPLC-MS/MS
BR112022024978A2 (en) FREE LIQUID CHROMATOGRAPHY METHODS TO QUANTIFY TARGET ANTIBODIES IN A SAMPLE AND TO QUANTIFY A PROTEIN DRUG PRODUCT IN A BIOLOGICAL SAMPLE